Southfield Receives $15 Million Bequest to Propel Leukemia Research Forward

Southfield’s Big Leap for Leukemia Research

In a heartwarming turn of events, Southfield-based Corewell Health has recently announced an incredibly generous gift that’s set to transform the landscape of leukemia research. Thanks to a whopping $15 million bequest from the estate of the late Harry Kirk Denler, the fight against this devastating disease is about to get a major boost.

A Lifelong Legacy

Harry Kirk Denler, who sadly passed away from leukemia back in 2002, had a deep connection to what is now known as Corewell Health William Beaumont University Hospital in Royal Oak. His passing marked a significant turning point in many lives, but it seems that his legacy has truly just begun. Following the death of his wife, Barbara Miriani Denler in early 2023, the remainder of his estate was allocated to Corewell Health, paving the way for groundbreaking research into both pediatric and adult leukemia.

Expressions of Gratitude

Members of the Corewell Health community have expressed heartfelt gratitude for this unexpected windfall. Lamont Yoder, a registered nurse and the president of Corewell Health East, shared just how impactful this gift will be. “All of us at Corewell Health are profoundly appreciative of Harry Kirk Denler who chose to include us in his estate plan and give a gift of such magnitude,” he said. His words underline the generosity and selflessness that Harry embodied throughout his life.

Another voice of appreciation came from Ryan Daly, president of the Corewell Health Foundation for Southeast Michigan, who stated, “This gift will transform leukemia research and will improve the lives of patients at Corewell Health and beyond.” His acknowledgement of Denler’s kindness shines a light on how this contribution will resonate well beyond just one institution.

A Purposeful Gift

Harry’s cousin Ben Robinson shared a touching insight into Denler’s motivations. He wanted to express his gratitude for the exceptional care he received while battling his illness. With no children, his decision to direct his estate toward leukemia research is a testament to his character—always looking to help others facing similar struggles. Robinson mentioned, “He wanted to help find a cure for leukemia so that others would not have to suffer from what he went through.” Now, his wish is becoming a reality.

Transformational Research Ahead

The funds from Denler’s estate will fuel pivotal investigations led by the Research Institute at Corewell Health. Dr. Richard Kennedy, senior scientific director for the Research Institute, shared that their focus will initially target pediatric leukemia, transitioning to adult cases later. This strategic approach allows researchers to build upon existing frameworks and move efficiently toward breakthroughs in treatment and diagnostics.

Leukemia is a condition that currently affects over 500,000 Americans, many of whom are either living with the disease or in remission. With Denler’s generous contribution, the potential to uncover advanced treatment options and, ultimately, a cure, is more tangible now than ever.

A Bright Future

The excitement in the air is palpable as Corewell Health gears up to honor Denler’s commitment with unwavering diligence and dedication. Dr. Kennedy remarked, “We are profoundly grateful for this support and will do our best to honor the hope and spirit in which Mr. Denler’s commitment was made.” It’s clear that this gift is not just a donation, but a vital stepping stone toward a future where leukemia may become less of a threat.

As Southfield and its surrounding communities rally behind this significant advancement in cancer research, one thing is certain—Harry Kirk Denler’s legacy will continue to shine brightly, impacting countless lives through this remarkable gift.

Author: HERE Novi